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Pancreatic fluid collections (PFCs) comprise a variable 
and heterogeneous group of pancreatic-derived exudates, 
commonly complicating pancreatitis.  Attempts have been 
made to clarify the different types of fluid collections, in par-
ticular with reference to the associated type of pancreatitis.1-5 
Associated pancreatic ductal abnormalities in chronic pancre-
atitis may also contribute to the development of these collec-
tions and determine the outcome of treatment. Over the last 
decade, advances in pancreatic endotherapy have resulted in 
an increased utilisation of non-operative techniques in the 
management of the different types of PFCs. The perceived 
lower morbidity associated with non-operative interventions 
has challenged the role of open surgery in the treatment of 
this common complication of pancreatitis. 
The variable morphology of PFCs has bedevilled attempts 
at formulating a classification that can be used to dictate 
treatment strategy and the validation thereof. A practical clas-
sification will allow appropriate stratification of these variable 
groups of PFCs, and facilitate critical audit and comparison 
of the different treatment modalities.   
Aetiology 
Pseudocyst formation is directly related to pancreatitis. 
Alcohol-related pancreatitis is the major cause in most series, 
accounting for 59 - 78% of pseudocysts.4 Variations in alco-
hol consumption of different population groups along with 
varying proportions of acute and chronic pancreatitis affect 
the prevalence of pseudocysts secondary to alcohol (Table I). 
Alcohol abuse is the principal cause of pseudocysts related 
to chronic pancreatitis, whereas pseudocysts may complicate 
the clinical picture of any cause of acute pancreatitis, includ-
ing pancreatic cancer and endoscopic retrograde cholan-
giopancreatography (ERCP). Pseudocysts may develop after 
surgery to neighbouring organs through inadvertent pancre-
atic injury.
Pancreatic trauma is a major cause of pseudocysts in cer-
tain series5 and in the paediatric population. Pseudocysts in 
children11,12 are well-recognised complications of acute pan-
creatitis and pancreatic trauma. The classic bicycle handlebar 
injury causes compression of the pancreas onto the vertebral 
column with secondary pancreatic duct disruption, which 
may be complicated by pseudocyst formation.
Incidence
The documented incidence of pseudocysts following acute 
pancreatitis has increased with the availability of ultrasound 
and computed tomography (CT). Adherence to current defi-
nitions1 is important for valid interpretation and comparison, 
as the majority of pancreatic fluid collections in acute pan-
creatitis will regress spontaneously2,13 and do not progress to 
pseudocyst formation. The incidence of pseudocyst forma-
tion following acute pancreatitis ranges from 55% to 12% in 
different series.14-17 One interpretation for the wide range is 
that in patients with acute-on-chronic pancreatitis, the mor-
phological changes of chronic pancreatitis may be missed,3 
particularly in uncomplicated cases where minimal testing 
is done, while in chronic pancreatitis, pseudocysts may be 
incorrectly labelled as a complication of acute pancreatitis. 
The incidence of pseudocysts in chronic pancreatitis may be 
higher, with some series reporting 20 - 40% occurrence.3,18,19 
The risk in the individual patient may be increased over their 
lifetime owing to the unremitting nature of chronic pancre-
atitis. 
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Review
Summary
Improvements in imaging studies and a better under-
standing of the natural history of pancreatic fluid collec-
tions (PFCs) have allowed the different types to be clari-
fied. Stratification of PFCs into subgroups should help in 
selecting from the increasing current available treatment 
options, which include percutaneous, endoscopic and 
surgical drainage. Percutaneous catheter drainage is 
safe and effective and should be the treatment of choice 
in poor-risk patients, and for infected pseudocysts re-
lated to acute pancreatitis. Endoscopic drainage should 
be the first management option in suitable pseudocysts 
related to chronic pancreatitis, if the necessary exper-
tise is available. The high success rate and current low 
morbidity of elective open surgery mean that it is still the 
standard of management in this disease. 
   Laparoscopic approaches are gaining favour, predomi-
nantly in drainage of collections in the lesser sac, and 
long-term data are awaited. The precise application of 
this modality will need to be critically compared with the 
low morbidity of mini-laparotomy, which is the current 
standard after non-operative treatment fails in these pa-
tients.
   It is essential to clearly stratify the different types of pan-
creatic pseudocysts, in particular with relation to acute 
or chronic pancreatitis, and perform a valid comparison 
of the different treatment modalities within groups. In 
this capacity a precise and transparent classification 
may provide valuable answers, in particular relating to 
optimal management according to pseudocyst type. 
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Pathogenesis
Two distinct groups of pseudocysts are evident when consid-
ering pathogenesis: pseudocysts related to acute pancreatitis 
and those related to chronic pancreatitis (intra- and extra-
pancreatic collections).
Pseudocysts following acute pancreatitis 
(post-necrotic)
Post-necrotic collections follow an attack of necrotising pan-
creatitis, with peripancreatic necrosis in the lesser sac which 
may extend into the retroperitoneum and bowel mesentery.20 
The evoked inflammatory response causes the formation of 
a distinct cyst wall composed of well-vascularised granula-
tion tissue, which organises with more connective tissue and 
fibrosis. The pseudocyst cavity may contain enzymatic fluid 
and necrotic debris.21 
Pseudocyst communication with the pancreatic duct in 
these post-acute collections is variable. Amylase levels in 
aspirated samples of pseudocyst fluid often far exceed serum 
levels and prolonged periods of drainage or pancreatic fistula 
formation may be expected following percutaneous interven-
tion.4 Communication may or may not persist because the 
progressive inflammatory reaction that parallels cyst forma-
tion may occlude the fistula.21 Different rates of pseudocyst-
duct communication are reported in the literature, ranging 
from very low (< 5%)5,22  up to 60%. 23
Pseudocysts related to chronic pancreatitis
Extrapancreatic
These pseudocysts may develop as a consequence of an acute 
flare-up or exacerbation of underlying chronic pancreatitis, 
with or without an associated focal area of pancreatic necro-
sis. These collections are often confined to the peripancreatic 
space, but may rupture into the lesser sac and then into the 
peritoneal cavity resulting in pancreatic ascites.1,20 
Intrapancreatic
In this group a second mechanism has been proposed: when 
a branch of the pancreatic duct is obstructed by fibrous scar-
ring, protein plug, or stone, the ongoing pancreatic secretion 
upstream of the obstruction leads to a saccular dilation of 
the duct, filled with pancreatic juice. Such a cyst is truly a 
retention cyst.5,13 Microcysts formed can eventually coalesce 
and lose their epithelial lining as they enlarge. In chronic 
pancreatitis, pseudocysts may be seen in those patients with 
minimal fibrosis as well as in those with advanced fibrosis 
and calculi.24 These cysts are commonly located in the head 
of the gland. Studies10,25 have demonstrated a high cyst duct 
communication (up to 60%) in this group of patients, par-
ticularly in the setting of a dilated (> 7 mm) main pancreatic 
duct.26
Traumatic pseudocysts
Pseudocysts following pancreatic trauma are usually the 
result of injury to the pancreatic duct or its major branches, 
applicable to both penetrating and blunt pancreatic trauma. 
The majority of pseudocysts in children are traumatic,27 
whereas in most adult series6-9 the incidence ranges from 3% 
to 6%. In countries with a higher trauma prevalence, such as 
South Africa, the rate increases to 10 - 22%.5,28
Clinical features and diagnosis
Patients with pseudocysts related to acute pancreatitis usu-
ally present with persistent pain, with or without upper gas-
trointestinal symptoms (i.e. anorexia, nausea and vomiting). 
Some patients may only present later, after the acute attack 
of pancreatitis has subsided, mimicking a recurrent attack of 
pancreatitis.  A smooth mass may be palpated in the epigas-
trium or the left upper quadrant, depending on pseudocyst 
size and patient body habitus. Features of gastric outlet 
and/or biliary obstruction may be present. Compression of 
the mediastinum has been reported when pancreatic fluid 
extends into the mediastinum.29 Patients with complicated 
cysts manifest features of sepsis, with a pyrexia and an elevat-
ed white cell count, or hypovolaemic shock in rare cases with 
significant bleeding into the pseudocyst.
In chronic pancreatitis the presentation may be insidious, 
especially when the patient has persistent opioid-depen-
dent pain. Features include persistent pain after an acute 
exacerbation, gastrointestinal symptoms and jaundice.30 
A persistently elevated serum amylase may occur in up to 
three-quarters of patients,4 but may be normal with impaired 
exocrine function in chronic pancreatitis. Ultrasound and 
CT scanning are commonly used to detect these collections. 
In view of potentially significant complications, ERCP is 
not routinely used as a diagnostic procedure,31 except as part 
of the work-up to exclude a cystic neoplasm of the pancre-
as.32-34  In future ERCP and/or MRCP may influence surgical 
management via demonstrating the underlying pancreatic 
duct abnormality.35,36  
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TAble I.  ConTRIbuTIng CAuSeS of PAnCReATIC PSeudoCySTS
Author (year)  Country           Pseudocyst              Alcohol          Biliary           Trauma          Other           Idiopathic
(No. of patients)                          type
d’egidio &  South Africa   Acute & chronic     70%               -      22%             -                  8%
Schein5 (1991)
(n = 83)
Walt et al.6 (1990) uSA            Acute & chronic      70%             8%               6.3%             -                   16%
(n = 357)
o’Malley et al.7        uSA            Acute & chronic     78%              7%      3%              6%               6%
(1985) (n = 69)
Kolars et al.8 uSA           Acute & chronic     73%             6%     3%              4%               14%
(1989) (n = 51)
bourliere &  france            Acute & chronic     70%             13%     3%             6%    8%
Sarles9 (1989)  
(n = 357)
usatoff et al.10 uK           Chronic                   71%             4%     -             5%    20%
(2002) (N = 112)
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natural history
Increased availability and application of accurate imaging by 
CT should improve our understanding of the natural history 
of PFCs. While there is general consensus that there is a dif-
ference in the resolution rate between PFCs following acute 
pancreatitis and those complicating chronic pancreatitis,3 
data are variable mainly because terminology and classifica-
tions differ in published series.37
Reported spontaneous resolution in PFCs related to acute 
pancreatitis varies from 20% to 65% of patients.38-40 Series 
that have not adhered to the Atlanta criteria have reported 
higher resolution rates, which may reflect the inclusion 
of predominantly post-acute fluid collections. There is no 
convincing evidence to indicate that resolution rates differ 
between pseudocysts related to the two major causes of acute 
pancreatitis (alcohol v. biliary).4,41,42
Earlier studies38,43 reported a low possibility of spontane-
ous resolution in pseudocysts that persist beyond 6 weeks 
after an attack of acute pancreatitis. This finding has been 
challenged in more recent studies,40-42 which have demon-
strated pseudocyst resolution well beyond this timeline. 
Most studies38,39,44,45 on the natural history of pseudocysts in 
chronic pancreatitis show a resolution rate of less than 10%. 
The diameter of 6 cm had previously been regarded as the 
upper limit beyond which resolution would not occur42,46 but 
this has subsequently been shown not to be the case.47 The 
great majority of pseudocysts less than 4 cm in diameter will 
resolve spontaneously.44,46
Complications
In the 1979 study by Bradley et al.,48 direct correlation of 
complications to the age of the PFC presence (with morbid-
ity rates of 76% after 13 weeks) and 12% related mortal-
ity was observed. This prompted the recommendation that 
‘delay is at best fruitless and at worst hazardous’. Subsequent 
studies40-42 of expectant pseudocyst management have dem-
onstrated much lower complication rates, between 3% and 
23%, and mortality below 1%. The obvious disparity can 
partly be attributed to the fact that the patients in the later 
studies selected for conservative management were asymp-
tomatic, whereas the cohort in Bradley’s series included 
patients with symptomatic PFCs, the majority of which were 
a consequence of acute pancreatitis. 
Classification
Terminology plays an integral part in the understanding 
and management of pancreatic pseudocysts and PFCs. 
Although the Atlanta symposium consensus1 has provided 
clear descriptions of the various PFCs and their natural his-
tory, its application in assessment of treatment strategy and 
outcome has not as yet been clearly determined.
A pseudocyst is defined as a collection of pancreatic juice 
enclosed by a wall of fibrous or granulation tissue, which 
arises as a consequence of acute pancreatitis, pancreatic 
trauma, or chronic pancreatitis. Formation usually requires 
4 or more weeks from the occurrence of acute pancreatitis,2 
or the lack of an antecedent acute episode when arising in 
the setting of chronic pancreatitis. An acute fluid collection is 
distinguished by occurring early in the course of acute pan-
creatitis, located adjacent to the pancreas, without having 
a wall of granulation or fibrous tissue. The term pancreatic 
abscess describes a circumscribed intra-abdominal collection 
of pus in proximity to the pancreas, containing little or no 
pancreatic necrosis, which arises as a consequence of acute 
pancreatitis or pancreatic trauma. Bacteria may be present in 
a pseudocyst, often representing contamination and thus of 
little clinical significance.1 When pus is present, the lesion is 
correctly termed a pancreatic abscess.
The current pseudocyst classifications are based on the 
preceding or concurrent type of pancreatitis,1 and the terms 
acute and chronic in this regard do not describe the known 
duration of the pseudocyst, but the underlying pancreatitis. 
Multiple classification systems have been proposed, based on 
pathogenesis, morphology, anatomical features or a combina-
tion thereof.5,20,49,50 
An early proposed classification49,50 of pancreatic pseu-
docysts depended on the association with acute or chronic 
pancreatitis. Acute pancreatitis pseudocysts were called 
necrotic cysts, as they resulted from pancreatic necrosis and 
extravasation of pancreatic secretions.  The term retention 
cyst was used in the setting of intra-pancreatic pseudocysts 
in chronic pancreatitis, as these were pathologically found 
to be true cysts caused by dilatation. Subsequent rupture 
into the peripancreatic tissues gives rise to extrapancreatic 
pseudocysts in chronic pancreatitis and not the sequelae of 
pancreatic necrosis.  
Subsequent classifications by D’Egido and Schein5 and 
Bornman et al.20 identified three distinct types of pseudo-
cysts: (i) ‘post necrotic’ or acute cysts that occur following 
acute pancreatitis, with normal pancreatic duct anatomy and 
without pancreatic duct communication; (ii) pseudocysts that 
follow an episode of acute-on-chronic pancreatitis (also post-
necrotic), where the pancreatic duct is diseased but not stric-
tured, and there is a significant incidence of duct-pseudocyst 
communication; and (iii) intrapancreatic ‘retention’-type 
pseudocysts, which occur with chronic pancreatitis and are 
uniformly associated with duct stricture and pseudocyst-duct 
communication. In these classifications, distinction between 
acute-on-chronic and chronic-type pseudocysts can be sub-
tle, usually requiring pancreatic duct delineation. Ultimately 
surgery may be required to show the presence of necrotic 
debris, indicating a recent flare-up of acute-on-chronic pan-
creatitis that may have been missed clinically.  Examples of 
the different pseudocyst types are demonstrated in Fig. 1.
A classification system based solely on pancreatic duct 
anatomy has been proposed by Nealon and Walser,51 on the 
postulate that the main pancreatic duct determines the type 
and course of the pseudocysts. It has been suggested that 
the definition of categories seen in ductal abnormalities may 
direct the choice of treatment modality. However, since duct 
morphology and duct communication are difficult to demon-
strate by imaging modalities, the value of incorporating this 
in formulating a classification is limited.  
Treatment  
Timing of intervention
Considering the vast literature on the natural history and 
complications of pseudocysts, it is reasonable to adopt an 
initial conservative approach in asymptomatic patients, on 
the basis that an appreciable proportion of pseudocysts will 
resolve spontaneously,38-42 particularly in the post-acute 
group. A diameter of 6 cm is no longer the threshold for 
intervention, with resolution documented in pseudocysts 
larger than this size.47 Logic dictates that the larger the 
pseudocyst and the longer the duration, the less likely that 
spontaneous resolution will occur and that the risk for com-
plications is increased. The same may be said in underlying 
chronic pancreatitis39 and pseudocysts with a thicker wall or 
known communication with the pancreatic duct. Provided 
that close clinical and radiological follow-up is undertaken, 
action can be taken when the pseudocyst increases in size or 
becomes symptomatic, or complications are suspected.
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Percutaneous drainage and acute/post-
necrotic pseudocysts
Percutaneous methods include aspiration and catheter 
drainage under radiological imaging. Aspiration is mostly 
useful for diagnosis but ineffective for therapy, as a high inci-
dence of re-accumulation can be expected,52 particularly in 
patients with pseudocyst duct communication. Gumaste and 
Pitchumoni53 reported a 63% rate of recurrence and 54% 
failure in an analysis of five studies. Despite this aspiration 
may play a selected role as primary management due to its 
low morbidity and ease of application. Aspiration may also 
contribute by sampling fluid for culture, amylase or tumour 
markers.
Percutaneous drainage is well established54 in the man-
agement of infected pseudocysts,55,56 as well as pancreatic 
abscesses and infected pancreatic necrosis.20 Success rates 
reported range between 13% and 90%, and are depen-
dent on the nature of the collection, catheter maintenance, 
replacement practice and duct communication. The results 
from major series are listed54 in Table II, with a cumulative 
success rate of 70% (235 of 334), 20% complication rate and 
mortality rate under 1%. In a thorough synopsis by Neff,57 
potential complications elucidated were: bleeding (1 - 2%), 
visceral/pleural injury (1 - 2%), secondary infection (9%), 
and formation of pancreatico-cutaneous fistula or recurrence. 
Adjunctive octreotide administration may decrease duration 
of required drainage and even fistula formation.58 
Unfortunately overlap between different PFCs does occur 
in reporting, which may bias the data. Percutaneous drainage 
should be the initial mode of treatment for poor-risk patients, 
for patients with infected pseudocysts, and when pseudo-
cyst rupture is imminent (rapidly expanding collection with 
increasing symptoms). It is not the treatment of choice in 
established chronic pancreatitis with associated strictures 
and communication of the pancreatic duct, as it will invari-
ably be complicated by pancreatico-cutaneous fistula.5,59 
Percutaneous pancreatic cyst gastrostomy has been reported 
with good success,20,53 but has not enjoyed widespread sup-
port. Fig. 2 demonstrates a CT scan after percutaneous 
pseudocyst drainage. 
Endoscopic therapy
The first endoscopic transgastric pseudocyst needle aspira-
tion was reported in 1975 by Rogers et al.,65 with the first 
successful transmural endoscopic drainage reported in 1985 
by Kozarek et al.66 Over the past decade a plethora of pub-
lished series mirror the increased popularity and application 
of these methods to the management of pancreatic pseudo-
cysts. 
Endoscopic options may be transenteric through the 
stomach (endoscopic cystgastrostomy), duodenum (endo-
scopic cystduodenostomy) or pancreatic duct (transpapillary 
drainage). These different approaches have been evaluated 
fig. 1. different pseudocyst classification types: (a) pseudocyst 
related to acute pancreatitis (post-necrotic); (b) extrapancre-
atic pseudocyst related to chronic pancreatitis; (c) intrapancre-
atic pseudocyst in chronic pancreatitis (retention).
fig. 2. Percutaneous pseudocyst drainage.
a
b
c
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in several large series, which allow assessment of their role in 
the management of pancreatic pseudocysts.
Transpapillary drainage
This is possible in pseudocysts that communicate with the 
pancreatic duct, ideally with a proximal duct obstruction or 
disruption in close proximity to the papilla.22,67 Technically 
demanding, this technique requires positioning of a coaxial 
guidewire system across the stricture and stent placement (5 
or 7F) into the pseudocyst, or across the site of the disrup-
tion. No significant difference exists with regard to whether 
the tip is placed into the pseudocyst or beyond the duct 
defect.68,69 In 1997 Beckingham et al.70 provided a detailed 
summary of reported series of transpapillary drainage. In 117 
patients successful drainage was achieved in 84%, with a 9% 
recurrence rate over a 2-year mean follow-up period. As can 
be expected drainage of pseudocysts situated in the tail of the 
pancreas was associated with more failures despite successful 
stent placement.71,72 The commonest complication was acute 
pancreatitis (5%). Concern has been expressed regarding 
stent-induced stricturing, but Huibregste et al.73 showed no 
clinical sequelae in patients 3 years after stenting.
Transmural drainage
Certain prerequisites are required before performing drain-
age in this manner. Only pseudocysts involving the head or 
body of the pancreas (which occur in 70%)20 are suitable. 
Ideally the pseudocyst should be adherent to the gastrointes-
tinal mucosa, there should be a visible bulge endoscopically, 
and the distance between bowel lumen and pseudocyst cavity 
as measured by CT or endoscopic ultrasound, should be less 
than 10 mm. Approximately half of chronic and 25% of acute 
pseudocysts are suitable for this approach. A needle knife 
is used to enter the pseudocyst cavity, followed by insertion 
of a guidewire/coaxial system. Most endoscopists place one 
or two temporary plastic stents to maintain communication. 
Enlarging the opening by excising a disc of tissue, while pro-
moting drainage, may increase bleeding rates.
Cumulative series of endoscopic cystgastrostomy reported 
success rates of 82%, recurrence rates of 18%, and 16% 
rates of major complications (8% bleeding, 8% perforation). 
In the cystduodenostomy group, the success rate was 89%, 
with a lower recurrence rate of 6%. Major complications 
were less frequent at 8% (4% bleeding, 4% perforation).70 
More recent series74,75 have supported these findings of a 
high success rate with major complication rates between 5% 
and 6%. Endoscopic drainage of pseudocysts with necrotic 
contents increases procedure-related complications,76 and 
is generally discouraged.28 Despite initial promise that it 
would assist transmural drainage, endoscopic ultrasound 
has not decreased complications, including bleeding. This 
was demonstrated by Kahaleh et al.77 in a prospective study 
comparing conventional with endoscopic ultrasound-guided 
drainage in 99 patients. Complications occurred in 19% of 
the endoscopic group and 18% of the conventional group.
Baron et al.78 sought to determine outcome differences 
after endoscopic drainage of pancreatic necrosis, acute and 
chronic pseudocysts. The success in the chronic pseudocyst 
(CP) group was significantly better (92%) than that in the 
acute pseudocyst (AP) group (74%). Differences in compli-
cation rates (CP 17% v. AP 19%), and recurrence (CP 12% 
v. AP 9%) were not significant. Patients with chronic pseu-
docysts spent significantly less time in hospital (3 v. 9 days). 
In a recent study of 170 patients from Helsinki79 the success 
rate was 86%, with a 10% complication rate; 13.9% required 
surgery for endoscopy failures.
Current available data suggest that endoscopic man-
agement provides an acceptable substitute to surgery. It 
is important to note that a significant level of expertise is 
required in order to perform these advanced procedures with 
high success and low morbidity.80 A summary of some of 
the series70,20 pertaining to endoscopic drainage is presented 
in Table III. Fig. 3 demonstrates an example of endoscopic 
cystgastrostomy on CT.
Surgical intervention
Open surgery
Surgery still plays an important role in the management 
of pancreatic pseudocysts. It is the treatment of choice 
for patients with recurrent pseudocysts, when less invasive 
methods fail, and for patients with a suspected neoplastic 
cyst. Open surgical procedures include internal drainage, 
external drainage and excision. External drainage is seldom 
performed and reserved for infected fluid collections, usually 
after failure of percutaneous methods and invariably in sick 
ARTICLES
TAble II. ReSulTS of PeRCuTAneouS dRAInAge of PAnCReATIC PSeudoCySTS 
                                                                     Mean                                                            
                                                                     drainage                                                                         
Author (year)                                                duration                                               Mean                                   Mean hospital
(No. of patients)      Failure    Failure       (d)               Mortality     Recurrence    follow-up   Complications  stay (d)
d’egidio et al.5       22 (96%)     nA             nA             0                  1 (4)               nA              2 (9%)              nA
(1991)  (n = 23)
Van Sonnenberg   91 (90%)      6 (6%)        20              0                  nA                 nA             10 (10%)          nA
et al.58 (n = 101)
Anderson et al.60   13 (60%)      3 (14%)      nA             0                 nA                 nA             nA                     30
(1989) (n = 22)
Spivak et al.61        17 (63%)       9 (33%)      nA             1                 6 (22%)          3 yrs          nA                    nA
(1998) (n = 27)
Adams et al.62         35 (67%)     17 (33%)    42              0                 nA                 nA             4 (8%) major    nA
(1992) (n = 52)                         25 (56%) drain
                        infection
grosso et al.63        29 (67%)      14 (33%)    nA             0                 9/38 (24%)    2 - 26         2 (7%)              nA
(1989) (n = 43)                   mo.
Heider et al.64         28 (42%)      38 (58%)     38               0                 nA                 nA             nA                    45
(1999) (n = 66)
NA = data not available.
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patients. This accounts for high mortality, recurrence and 
fistula rates of over 10%.81  
Internal drainage options include cystgastrostomy (Fig. 
4), cystduodenostomy and cystjejunostomy. Anatomical posi-
tion of the cyst determines the most appropriate procedure. 
Principles include aspiration of cyst fluid for localisation and 
amylase, enterotomy and stay suture placement into the cyst 
wall before opening. A portion of the cyst wall is removed for 
histological examination and the bowel pseudocyst commu-
nication is circumferentially sutured to maintain patency and 
haemostasis. Mortality in studies from the late 1990s81 is 3% 
with an 8% recurrence rate.
Excision of pseudocysts in the tail or body by distal pan-
createctomy (with or without splenectomy) is indicated for 
complicated pseudocysts, or when there is contiguous exten-
sion into the splenic hilum.
Laparoscopic pseudocyst drainage 
Enthusiasm for and perceived benefits of laparoscopic sur-
gery have been extended to drainage of pancreatic pseu-
docysts. The principles of open surgery with the creation 
of a dependent cyst enterostomy can be achieved via this 
minimal access approach. Laparoscopic cystgastrostomy is 
the most commonly performed laparoscopic procedure for 
pseudocysts located in the lesser sac. Variations of the proce-
dure include endogastric,82-89 transgastric82,90-92 and extragas-
tric82,93,94 approaches.  Access to the posterior gastric wall is 
gained through the introduction of ports including the lapa-
roscope (endogastric), an anterior gastrotomy (transgastric), 
or via the lesser sac (extragastric). An endoscopically assisted 
laparoscopic approach has also been described.95 More dis-
tal pseudocysts have been drained through variable types of 
Roux-en-Y laparoscopic cystjejunostomy.88,96,97
Initial results indicate a success rate of 77 - 100%, with 
a complication rate of 8 - 17% and no mortality or recur-
rence.82,84,86,89,92 Total reported numbers are small and larger 
series are required for meaningful comparison with other 
treatment modalities, open surgery in particular.
Comparison of treatment options
There are currently no prospective randomised trials com-
paring the various approaches in the management of pancre-
atic pseudocysts. High complication and mortality rates were 
reported in historical surgical series,43,98,99 which can bias cur-
rent interpretation and comparison with other approaches. 
More recent complication rates13,51,100 have been in the region 
of 5 - 15%, with little or no mortality. These results, com-
bined with the very low rate of recurrence with surgery, mean 
that this option is still the standard by which other manage-
ment approaches are measured. 
Numerous retrospective studies have compared percu-
taneous to surgical drainage, predominantly concerning 
pseudocysts following acute pancreatitis. While earlier stud-
ies showed a higher mortality in the surgical group,60 later 
comparisons62 showed no difference. When all variables were 
taken into account, as reported by Lang et al.,101 the results 
were similar. High secondary tract infection and prolonged 
pancreatic drainage (mean drainage of up to 42 days) via 
the catheter was reported in certain studies of percutaneous 
drainage.
Similar results in terms of success, morbidity and mor-
tality have been reported in two retrospective studies102,103 
comparing endoscopic drainage with surgery.  Nealon and 
Walser, however,104 issue a caution regarding the potential 
complications of non-surgical methods and stress the role 
of surgery in managing these. They retrospectively reviewed 
79 patients with complications following non-operative mea-
sures, 66 (84%) of whom required subsequent operation. Of 
ARTICLES
TAble III. SuMMARy of endoSCoPIC PSeudoCyST dRAInAge70,20
Endoscopic                                    Initial                                                                                                                   Follow-up
modality Patients        success  Complications Recurrence Long-term success    (mo.)
                      
Transpapillary  117         98 (84%) 14 (12%)  10 (9%)   88 (75%)      15 - 37
                 
Cystgastrostomy  50       41 (82%) 11 (22%)  9 (18%)   32 (64%)      9 - 48
                 
Cystduodenostomy 71        63 (89%) 7 (10%)  4 (6%)  59 (83%)       9 - 48
fig. 3.  endoscopic cystgastrostomy (arrow indicates endo-
scopic stent).
fig. 4. Surgical pseudocyst gastrostomy.
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note is the low complication rate (6%) in the historical com-
parative surgical group of 100 patients in this experienced 
surgical unit. The higher efficacy of surgical management of 
pancreatic pseudocysts compared with non-invasive methods 
needs to be taken into consideration when comparing differ-
ent management modalities.
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